Marker Therapeutics annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
Marker Therapeutics Operating Margin Growth & History (MRKR)
Marker Therapeutics's operating margin was −363.45% for fiscal 2025.
View full Marker Therapeutics company overviewMarker Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −363.45% | −194.76 pp |
| 2024 | 2024-12-31 | −168.69% | +271.69 pp |
| 2023 | 2023-12-31 | −440.37% | +122.90 pp |
| 2022 | 2022-12-31 | −563.28% | +2616.05 pp |
| 2021 | 2021-12-31 | −3,179.32% | +3008.92 pp |
| 2020 | 2020-12-31 | −6,188.25% | +4379.03 pp |
| 2019 | 2019-12-31 | −10,567.28% | +61362.79 pp |
| 2018 | 2018-12-31 | −71,930.07% | −65659.02 pp |
| 2017 | 2017-12-31 | −6,271.05% | — |
Marker Therapeutics quarterly operating margin
Q3.17
Q2.18
Q2.20
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −541.78% | +878.36 pp |
| Q4 2025 | 2025-12-31 | −61.05% | +110.43 pp |
| Q3 2025 | 2025-09-30 | −173.30% | −48.70 pp |
| Q2 2025 | 2025-06-30 | −594.79% | −397.39 pp |
| Q1 2025 | 2025-03-31 | −1,420.14% | −1215.25 pp |
| Q4 2024 | 2024-12-31 | −171.48% | +106.58 pp |
| Q3 2024 | 2024-09-30 | −124.60% | +1117.62 pp |
| Q2 2024 | 2024-06-30 | −197.40% | +344.66 pp |
| Q1 2024 | 2024-03-31 | −204.89% | +144.24 pp |
| Q4 2023 | 2023-12-31 | −278.06% | −422.79 pp |
| Q3 2023 | 2023-09-30 | −1,242.22% | −659.33 pp |
| Q2 2023 | 2023-06-30 | −542.06% | +124.42 pp |
| Q1 2023 | 2023-03-31 | −349.13% | +666.58 pp |
| Q4 2022 | 2022-12-31 | 144.73% | +1506.72 pp |
| Q3 2022 | 2022-09-30 | −582.90% | +1686.00 pp |
| Q2 2022 | 2022-06-30 | −666.47% | +1512.82 pp |
| Q1 2022 | 2022-03-31 | −1,015.71% | — |
| Q2 2020 | 2020-06-30 | −1,361.99% | — |
| Q2 2018 | 2018-06-30 | −2,268.90% | — |
| Q3 2017 | 2017-09-30 | −2,179.30% | — |
Marker Therapeutics operating margin trends
Over the last five reported fiscal years, Marker Therapeutics's operating margin increased from −6,188.25% to −363.45%, a change of +5824.80 percentage points. The latest reported quarter, Q1 2026, shows −541.78%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Marker Therapeutics filings at SEC.gov ↗